AIMEDBIO

IR

Disclosure

54 posts
NO. Title Date Author
34 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) 2026-02-06 에임드바이오
33 Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) 2026-02-06 에임드바이오
32 Report on status of specific securities, etc. owned by executives and major shareholders 2026-02-05 인터베스트
31 Report on significant holdings of stocks, etc. (Short form) 2026-02-05 인터베스트
30 Relocation of Corporate Headquarters 2026-01-30 에임드바이오
29 Report on status of specific securities, etc. owned by executives and major shareholders 2026-01-09 허남구
28 Report on status of specific securities, etc. owned by executives and major shareholders 2026-01-09 안선희
27 Report on status of specific securities, etc. owned by executives and major shareholders 2026-01-09 민병귀
26 Report on status of specific securities, etc. owned by executives and major shareholders 2026-01-09 김태경
25 Report on status of specific securities, etc. owned by executives and major shareholders 2026-01-09 김미현
1 2 3 4 5